gms | German Medical Science

20. Deutscher Kongress für Versorgungsforschung

Deutsches Netzwerk Versorgungsforschung e. V.

06. - 08.10.2021, digital

Effect of the COVID-19 pandemic on stress, anxiety, and depressive disorders in German primary care: a cross-sectional study based on claim data

Meeting Abstract

  • Bernhard Michalowsky - Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Greifswald, Deutschland
  • Karel Kostev - Frankfurt am Main, Deutschland
  • Steffi G. Riedel-Heller - Institute for Social Medicine, Occupational Medicine, and Public Health (ISAP) of the Medical Faculty at the University of Leipzig, Leipzig, Germany
  • Wolfgang Hoffmann - Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Greifswald, Deutschland
  • Jens Bohlken - Berufsverband Deutscher Nervenärzte, Berlin, Deutschland

20. Deutscher Kongress für Versorgungsforschung (DKVF). sine loco [digital], 06.-08.10.2021. Düsseldorf: German Medical Science GMS Publishing House; 2021. Doc21dkvf423

doi: 10.3205/21dkvf423, urn:nbn:de:0183-21dkvf4238

Published: September 27, 2021

© 2021 Michalowsky et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Background: Several studies revealed that mental disorders' prevalence increased during the COVID-19 pandemic, particularly in young and female individuals. Such studies represent individuals' subjective perceptions and not the number of mental health cases treated in primary care.

Objectives: Thus, this study aimed to describe the changes in depression, anxiety, and stress disorder diagnoses in General Practitioner (GP) practices during the COVID-19 pandemic.

Methods: More than three million patients of 757 German GP practices were included in this cross-sectional analysis. Descriptive statistics were used to assess changes in the number of incident depression (ICD-10: F32, F33), anxiety disorders (F41), and reaction to severe stress and adjustment disorders (F43) documented by GPs in 2020 compared to the average of the years 2017 to 2019.

Results: There was a tremendous decrease in mental health diagnoses during the first lockdown that was only slightly compensated later. Overall populations and the entire year 2020, there was no change in documented depression (0%) and stress disorders (1%), but anxiety disorders were more often documented (+19%), especially for the elderly population (>80years; +24%). This population group also received more frequently new depression (+12%) and stress disorder diagnoses (23%). The younger population was diagnosed more frequently at the end of 2020, nine months after the first lockdown.

Discussion: Anxiety disorders but not depression and stress diagnoses were elevated, which is not in line with previously published studies. We speculate that the elderly population was affected most by the pandemic immediately after the first lockdown was announced. The younger population has probably become more and more affected the longer the pandemic lasts.

Implication: The elderly population was affected most and immediately by the introduced measures of the COVID-19 pandemic and, therefore, demonstrated an elevated rate of depression, anxiety and stress disorders, which should be addressed in the current primary care system.

Plea to the practice: Prospective studies should evaluate the long-term effects of lockdowns on patient-related outcomes.